U.S. markets closed

Perrigo Company plc (0Y5E.L)

LSE - LSE Delayed Price. Currency in USD
Add to watchlist
75.69+21.80 (+40.45%)
At close: 11:52AM BST

Perrigo Company plc

The Sharp Building
Hogan Place
Dublin 2
Ireland
353 1 709 4000
http://www.perrigo.com

Sector(s)
Industry
Full Time Employees11,000

Key Executives

NameTitlePayExercisedYear Born
Mr. Murray S. KesslerCEO, Pres & Director3.06MN/A1960
Mr. Raymond P. SilcockCFO, Principal Accounting Officer & Exec. VP1.48MN/A1951
Mr. James E. Dillard IIIExec. VP & Chief Scientific Officer1.01MN/A1964
Mr. Jeffrey R. NeedhamExec. Officer1.11MN/A1956
Mr. Svend AndersenExec. VP & Pres of Consumer Healthcare International1.08MN/A1962
Amounts are as of December 31, 2019 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Perrigo Company plc manufactures and supplies over-the-counter health and wellness solutions in the United States, Europe, and internationally. The company operates through Consumer Self-Care Americas, Consumer Self-Care International, and Prescription Pharmaceuticals segments. It provides upper respiratory, pain and sleep-aids, digestive health, nutrition, vitamins, minerals and supplements, healthy lifestyle, skincare and personal hygiene, and oral self-care products under the Prevacid 24HR, Good Sense, Zephrex D, ScarAway, Plackers, Steripod, and Rembrandt brand names. The company also develops, manufactures, and markets a portfolio of generic prescription drugs, such as creams, ointments, lotions, gels, shampoos, foams, suppositories, sprays, liquids, suspensions, solutions, powders, controlled substances, injectable, hormones, oral solid dosage forms, and oral liquid formulations. In addition, it offers contract manufacturing services. The company offers its products through retail drug, supermarket, and mass merchandise chains; hospitals; pharmacies; wholesalers; drug and grocery stores; and para pharmacies, as well as through a network of pharmacy sales force. Perrigo Co. plc has a partnership with NetworkWire to license Witi's patent-pending hardware and software IP in development of a smoking cessation product. Perrigo Company plc was founded in 1887 and is headquartered in Dublin, Ireland.

Corporate Governance

Perrigo Company plc’s ISS Governance QualityScore as of December 8, 2019 is 5. The pillar scores are Audit: 3; Board: 8; Shareholder Rights: 4; Compensation: 6.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.